INTERNATIONAL PATENT: ORUM THERAPEUTICS, INC. FILES APPLICATION FOR "ANTI-CD123 ANTIBODIES AND NEODEGRADER CONJUGATES"

GENEVA, April 6 -- ORUM THERAPEUTICS, INC. (2F, 281-25, Munji-roYuseong-guDaejeon 34050) filed a patent application (PCT/IB2025/059859) for "ANTI-CD123 ANTIBODIES AND NEODEGRADER CONJUGATES" on Sep 30, 2025. With publication no. WO/2026/069278, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHOI, Dong-Ki (c/o Orum Therapeutics, Inc.1050 Waltham Street, Suite 101Lexington, Massachusetts 02421), KIM, Da-Yeong (c/o Orum Therapeutics, Inc.1050 Waltham Street, Suite 101Lexington, Massachusetts 02421), KIM, Min-Soo (c/o Orum T...